Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
International Journal of Molecular Sciences|May 7, 2025
Immunohistochemical Profiling of IDO1 and IL4I1 in Head and Neck Squamous Cell Carcinoma: Interplay for Metabolic Reprogramming?Benedikt Schmidl, Maren Lauterbach, Fabian Stögbauer, et al.Virchows Archiv : an International Journal of Pathology|July 2, 2022
Deglycosylation of pathological specimens alters performance of diagnostic PDL1 antibodiesFranz F Dressler, Devang S Dabadghao, Luise Klapper, et al.Oncology Letters|June 23, 2020
PSMD9 expression correlates with recurrence after radiotherapy in patients with cervical cancerFrank Köster, Lisa Sauer, Friederike Hoellen, et al.Journal of Perinatal Medicine|February 12, 2011
miRNA expression profiling in formalin-fixed and paraffin-embedded placental tissue samples from pregnancies with severe preeclampsiaFrank Noack, Julika Ribbat-Idel, Christoph Thorns, et al.Frontiers in Oncology|June 2, 2023
Prognostic impact of the loss of E-cadherin and <i>de novo</i> expression of N-cadherin at the invasive front of primary and recurrent oral squamous cell carcinomaSamer George Hakim, Clara Taubitz, Steffen Hoppe, et al.Biomedicines|June 24, 2022
Increased Abundances of CD16<sup>+</sup> Non-Classical Monocytes Accompany with Elevated Monocytic PD-L1 and CD4<sup>+</sup> T Cell Disturbances in Oropharyngeal CancerChristian Idel, Christina Polasky, Julika Ribbat-Idel, et al.International Journal of Molecular Sciences|May 14, 2022
Elevated LSD1 and SNAIL Expression Indicate Poor Prognosis in Hypopharynx CarcinomaJustus Bottner, Julika Ribbat-Idel, Luise Klapper, et al.Scientific Reports|June 12, 2020
In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulationRosemarie Krupar, Christian Watermann, Christian Idel, et al.Anticancer Research|June 4, 2021
Palliative Local Radiotherapy for Advanced Squamous Cell Carcinoma of the Head-and-Neck: Prognostic Factors of SurvivalChristian Staackmann, Julika Ribbat-Idel, Sven Perner, et al.Cancers|February 15, 2022
CDK7 Predicts Worse Outcome in Head and Neck Squamous-Cell CancerTobias Jagomast, Christian Idel, Luise Klapper, et al.Pageof 5